Keywords:
плазма, обогащенная растворимыми факторами тромбоцитов человека; методы получения, медицинское применение.References
Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac. Surg 1997; 55:1294-9.
Borzini P., Mazzucco L. Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion. 2005; 45: 1759-67.
Borzini P., Mazzucco L. Platelet gels and releasates. Curr. Opin. in Hematology. 2005; 12: 473-9.
Bogdan V.G., Bagatka S.S., Yurkevich M.Y. et al. Effects of platelet-rich plasma on viability, growth rate, morpho-phenotypical and secretory features of human adipose mesenchymal stem cells. Medicinskiy zhurnal. 2011; 1: 27-9. (in Russian)
Andia I., Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen. Med. 2013; 8 (5): 645-58.
Potapnev M.P., Arabey A.A., Kondratenko G.G. et al. Soluble preparations of platelet-derived growth factors and their medical implementation. Healthcare. 2014; 9: 32-40. (in Russian)
Drago L., Bortolin M., Vassena Ch. et al. Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: An in vitro study. PLoS ONE. 2014; 9(9): e107813.
Cohn C.S., Lockhart E., McCullough J.J. The use of autologous platelet-rich plasma in the orthopedic setting. Transfusion. 2015; 55: 1812 – 20.
Knezevic N.N., Candido K.D., Desai R., Kaye A.D. Is platelet-rich plasma a future therapy in pain management? Med Clin N Am. 2016; 100: 199-217.
Piccin A., Di Pierro A.M., Canzian L. et al. Platelet gel: a new therapeutic tool with great potential. Blood Transfusion. 2016; 1-8.
Aprili G., Gandini G., Guaschino R. et al. SIMTI recommendations on blood components for non-transfusional use. Blood Transfusion. 2013; 11(4): 611– 22.
Greppi N., Mazzucco L., Galetti G. et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals. 2011; 39: 73-80.
Bogdan V.G., Tolstov D.A., Bagatka S.S., Zafranskaya M.M. Biological effects of platelet concentrates in the culture of human dermal fibroblasts. Medicinskiy zhurnal. 2012; 2: 22-25. (in Russian)
Dohan Ehrenfest D.M., Sammartino G., Shibli J.A. et al. Guidelines for the publication of articles related to platelet concentrates (Platelet-Rich Plasma – PRP, or Platelet-Rich Fibrin – PRF): the international classification of the POSEIDO. Poseido J. 2013; 1 (1): 17-28.
Crovetti G., Martinelli G., Issi M. et al. Platelet gel for healing cutaneous chronic wounds. Transfusion and Apheresis Science. 2004; 30: 145-51.
Kondratenko G.G., Potapnev M.P., Troyanov A.A. et al. Method of the topical therapy of diabetic skin ulcers in patients suffering with diabetes mellitus. Instruction for use, adopted by Ministry of Health the Republic of Belarus on November 4, 2015, # 085-0915. (in Russian)
Bogdan V.G., Tolstov D.A. Clinical efficacy of autodermaplasty using platelet-rich autoplasma at plastic closure of trophic ulcers of venous etiology large size. Voennaya Medicina. 2015; 2: 65-9. (in Russian)
Kontopodis N., Tavlas E., Papadopoulos G. et al. Effectiveness of platelet-rich plasma to enhance healing of diabetic foot ulcers in patients with concomitant peripheral arterial disease and critical limb ischemia. Int. J. Lower Extrem. Wounds.2015; 1-7.
Andia I., Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews. Rheumatology. 2013. 9: 721- 730.
Mazzocca A.D., McCarthy M.B.R., Chowaniec D.M. et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surgery, 2012; 94-A (4): 308-16.
DeLong J.M., Russell R.P., Mazzocca A.D. Platelet-rich plasma. The PAW classification system. Arthroscopy. 2012S; 28 (7): 998-1009.
Alvarez-Camino J.-C., Vazquez-Delgado E., Gay-Escoda C. Use of autologous conditioned serum (Orthokine®) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature. Med Oral Cir Buccal. 2013-18 (3): e433- 8.
Fiorentino S., Roffi A., Filardo G. et al European definitions, current use, and EMA stance of platelet-rich plasma in sport medicine. J Knee Surg. 2015; 28 (01): 051- 4.
Anitua E., Prado R., Orive G. A new regulation framework for platelet-rich plasma in Spain. J. Knee Surg. 2015; 28 (4): 355-6.
Harm S.K., Fung M.K. Platelet-rich plasma injection: out of control and on the close? Transfusion. 2015; 55 (7): 1596 -1598.
Beitzel K., Allen D., Apostolakos J. et al. US Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine. J Knee Surg 2015; 28 (1): 029-034.
Jadlowiec C., Brennes R., Li X., Protack C. et al. Stem cell therapy for critical limb ischemia: what can we lean from cell therapy for chronic wounds? Vascular. 2012; 20 (5): 284-9.
Mazzucco L., Balbo V., Guaschino R. “Reasonable compromise” to define the quality standards of platelet concentrate for non-transfusion use (CPunT). Transfusion and Apheresis Science. 2012; 47 (2): 207- 11.
Dohan Ehrenfest D.M., Andia I., Zumstein M.A. et al. Classification of platelet concentrates (Platelet-Rich Plasma – PRP, Platelet-Rich Fibrin – PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implication and perspectives. Muscles, Ligaments and Tendons J. 2014; 4(1): 3-9.
Zhu Y., Yuan M., Meng H.Y. et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis and Сartilage. 2013; 21: 1627- 37.
Bogdan V.G., Tolstov D.A. Prospective randomized clinical trials of efficiency of autologous platelet-derived concentrates to stimulate regeneration of trophic ulcers of venous etiology. Novosti Khirurgii. 2014; 22 (3): 344- 50. (in Russian)
Carter M.J, Fylling C.P., Parnell L.K. Use of platelet-rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty.-2011; 11: art. e38.
Yamada T., Onishi K., Utsunomiya M., Nakamura M. Our treatment strategy for critical limb ischemia. Int,J Vascular Med. Vol. 2013, Article ID 437471, 5 pages.
Bae J.H., Kim Y.K., Myung S.K. Effect of platelet-rich plasma on sinus bone graft: meta-analysis. J. Periodontol. 2011; 82 (5): 660- 7.
Zhang Y., Tangl S., Huber Ch.D. et al. Effects of Choukroun’s platelet-rich fibrin on bone regeneration in combination with deproteinized bovine bone mineral in maxillary sinus augmentation: A historical and histomorphological study. J. Cranio-Max.-Fac. Surgery. 2012; 40 (4); 321- 8.
Grichanjuk D.A. Platelet-enriched plasma for surgical therapy of congenital cleft lip and palate. Sovremennaya stomatologiya (Minsk). 2006; (2): 43- 8. (in Russian)
Semenov F.V., Yakobashvili I.Yu. Usage of platelet-enriched plasma as hemostatic and analgesic medication in tonsillectomy. Vestnik Otorinolaringologii 2007; (6): 48–50. (in Russian)
Sukovatykh B.S., Orlova A. Y., Artjushkova E.B. Influence of plasma enriched with platelets and of the preparation “Myelopid” on the course of acute and chronic ischemia of the lower limbs Novosti Khirurgii. 2012; 20 (2): 41 – 8. (in Russian)
Ahmerov R., Zarudiy P., Richkova I., Bochkova O. Plasmolifting as the method of aged skin atrophy therapy by using platelet-enriched autoplasma. Aesteticheskaya medicina. 2011;.Х (2): 3- 9. (in Russian)
Federal Register. Part II. Department of Health and Human Services // Federal Register. 2006; 71 (167): 51276 - 367.
Lohman M., Walenda G., Hemeda H. et al. Donor age of human platelet lysate affect proliferation and differentiation of mesenchymal stem cells. PLosONE. 2012; 7(5): e37839.
Shan G.-G., Zhang Y.-N., Ma J. et al. Evaluation of the effects of Homologous Platelet gel on healing Lower extremity wounds in patients with diabetes. Intern. J. Lower Extremity Wounds. 2016. 12 (1): 22- 9.
Bottegoni C., Dei Giudici L., Salvemini S. et al. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Ther Adv Musculoskel Dis. 2016: 8 (2): 35-41.
Smith J.D., Weiss L.E., Burgess J.E. et al. Biologically active blood plasma-based biomaterials as a new paradigm for tissue repair therapies. Disruptive Science and Technology. 2012/2013; 1(3): 127- 37.
Potapnev M.P., Kondratenko G.G., Troyanov A.A. et al. Blood autodonation possibilities for platelet-rich plasma preparation to treat diabetic food ulcers. Medicinskiy Journal. 2016; (2): 91- 94. (in Russian)
Anitua E., Prado R. Allogeneic platelet-rich plasma: at the dawn of an off –the-shelf therapy? Trends in Biotechnology. 2017; 35 (2): 91-93. https://doi.org/10.1016/j.tibtech.2016.11.001
Богдан В.Г., Багатка С.С., Юркевич М.Ю., Зафранская М.М., Гаин Ю.М. Влияние обогащенной тромбоцитами плазмы на жизнеспособность, скорость роста, морфо-фенотипические и секреторные особенности мезенхимальных стромальных клеток жировой ткани человека. Медицинский журнал (Минск). 2011; (1): 27–29.
Потапнев М.П., Арабей А.А., Кондратенко Г.Г., Троянов А.А., Космачева С.М., Игнатенко С.И. и др. Растворимые факторы тромбоцитов и регенеративная медицина. Здравоохранение (Минск), 2014; (9): 32-40.
Богдан В.Г., Толстов Д.А., Багатка С.С., Зафранская М.М. Биологические эффекты тромбоцитарных концентратов в культуре фибробластов кожи человека. Медицинский журнал (Минск). 2012; (2): 22-25.
Кондратенко Г.Г., Потапнев М.П., Троянов А.А., Арабей А.А., Храпов И.М. Метод местного лечения диабетических язв кожи у пациентов с сахарным диабетом. Инструкция по применению. утверждена Министерством здравоохранения Республики Беларусь от 4 ноября 2015 г., регистр. № 085-0915.
Богдан В.Г., Толстов Д.А. Клиническая эффективность аутодермопластики с использованием обогащенной тромбоцитами аутоплазмы при пластическом закрытии трофических язв венозной этиологии больших размеров. Военная медицина. 2015; (2): 65-69.
Богдан В.Г., Толстов Д.А. Проспективное рандомизированное клиническое исследование эффективности применения аутологичных тромбоцитарных концентратов для стимуляции регенерации трофических язв венозной этиологии. Новости хирургии. 2014; 22 (3): 344-350.
Гричанюк Д.А. Обогащенная тромбоцитами плазма крови в хирургическом лечении врожденных расщелин верхней губы и неба. Современная стоматология.2006; (2): 43-48.
Семенов Ф.В., Якобашвили И.Ю. Применение обогащенной тромбоцитами плазмы в качестве гемостатического и аналгезирующего средства при тонзилэктомии. Вестник оториноларингологии. 2007; (6): 48-50.
Суковатых Б.С., Орлова А.Ю., Артюшкова Е.Б. Влияние плазмы, обогащенной тромбоцитами, и препарата «Миелопид» на течение острой и хронической ишемии нижних конечностей. Новости хирургии. 2012; 20 (2): 41- 48.
Ахмеров Р., Зарудий Р., Рычкова И., Бочкова О. Плазмолифтинг (Plasmolifting) - лечение возрастной атрофии кожи богатой тромбоцитами аутоплазмой. Эстетическая медицина. 2011; т.Х (2): 3-9.
Потапнев М.П., Кондратенко Г.Г., Троянов А.А., Карман А.Д., Кривенко С.И., Назарова Е.А., Левандовская О.В. Возможность аутодонорства крови при получении плазмы, обогащенной растворимыми факторами тромбоцитов, для лечения диабетических язв кожи. Медицинский журнал (Минск). 2016; (2): 91-94.